Lazard Asset Management’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120M Buy
2,886,295
+288,773
+11% +$11.6M 0.18% 125
2026
Q1
$94M Buy
2,597,522
+96,253
+4% +$3.69M 0.15% 142
2025
Q4
$96.2M Buy
2,501,269
+986,402
+65% +$37.1M 0.16% 140
2025
Q3
$24.9M Buy
1,514,867
+332,648
+28% +$11.6M 0.03% 278
2025
Q2
$40.5M Buy
1,182,219
+564,093
+91% +$17.9M 0.06% 254
2025
Q1
$23.2M Buy
618,126
+134,450
+28% +$4.39M 0.04% 318
2024
Q4
$15.5M Buy
483,676
+37,331
+8% +$1.21M 0.02% 389
2024
Q3
$14.6M Buy
446,345
+47,917
+12% +$1.51M 0.02% 393
2024
Q2
$12.4M Buy
398,428
+36,138
+10% +$1.08M 0.02% 478
2024
Q1
$10.8M Buy
+362,290
New +$10.3M 0.01% 525

Other funds holding QLTY

Lazard Asset Management's QLTY Position: Q2 2026 in Review

Lazard Asset Management increased its GMO US Quality ETF (QLTY) stake by 11% in Q2 2026, buying an estimated $11.6M and bringing the position to 2,886,295 shares worth $120M. The position accounts for 0.18% of the portfolio, ranked #125.

Lazard Asset Management first reported a position in QLTY in Q1 2024 and has held it in 10 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Lazard Asset Management held 2,886,295 shares of GMO US Quality ETF worth $120M as of Q2 2026.
  • Lazard Asset Management bought 288,773 GMO US Quality ETF shares in Q2 2026, an estimated $11.6M.
  • GMO US Quality ETF made up 0.18% of Lazard Asset Management's portfolio in Q2 2026, its #125 holding.
  • Lazard Asset Management first reported a position in GMO US Quality ETF in Q1 2024 and has held it in 10 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.